D Wayne Taylor
The Cameron Institute, Cambridge, ON, Canada
At the margins of the orphan drug world are found what have become known as dormant drugs or dormant therapies – drugs that have been abandoned as they failed to meet designated clinical endpoints in their development and for whom patents have expired. There are also literally millions of compounds disclosed in old patents that cannot be patented again and were overlooked in favor of a few. If partial research and/or development has been done on compounds and drugs, whether failed or not, then that experience must be protected to incent firms to mine the wealth of science already completed in the hopes of finding effective therapies for some of the most debilitating and lethal diseases known.
Read the full TCI report: Dormant therapies- hope for the rare disease community